 | • レポートコード：MRC2-11QY11380 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は循環腫瘍細胞（CTC）＆がん幹細胞のグローバル市場について調査・分析したレポートです。種類別（細胞濃縮、検出、CTC分析）市場規模、用途別（病院、NSC、医学研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別循環腫瘍細胞（CTC）＆がん幹細胞の競争状況、市場シェア ・世界の循環腫瘍細胞（CTC）＆がん幹細胞市場：種類別市場規模 2015年-2020年（細胞濃縮、検出、CTC分析） ・世界の循環腫瘍細胞（CTC）＆がん幹細胞市場：種類別市場規模予測 2021年-2026年（細胞濃縮、検出、CTC分析） ・世界の循環腫瘍細胞（CTC）＆がん幹細胞市場：用途別市場規模 2015年-2020年（病院、NSC、医学研究所） ・世界の循環腫瘍細胞（CTC）＆がん幹細胞市場：用途別市場規模予測 2021年-2026年（病院、NSC、医学研究所） ・北米の循環腫瘍細胞（CTC）＆がん幹細胞市場分析：米国、カナダ ・ヨーロッパの循環腫瘍細胞（CTC）＆がん幹細胞市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの循環腫瘍細胞（CTC）＆がん幹細胞市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の循環腫瘍細胞（CTC）＆がん幹細胞市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの循環腫瘍細胞（CTC）＆がん幹細胞市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：QIAGEN Hannover、AVIVA Biosciences、Epic Sciences、ApoCell、Cynvenio Biosystems、Fluxion Biosciences、Rarecells、Janssen Diagnostics、CellTraffix、Silicon Biosystems、Advanced Cell Diagnostics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the capacity of self-renewal. Cancer stem cells are the cancer cells that possess the characteristics of normal stem cells. Cancer stem cells are said to be responsible for relapse of cancers in patients. There is a growing interest in these two cell types due to their fundamental biological and clinical implications. Circulating tumor cells and cancer stem cells are an important element in order to understand cancer related mechanism and to find a cure from all type of cancers. These cells can be used for detecting of metastasis and the patients who are at a higher risk of cancer relapse.
The global circulating tumor cells and cancer stem cells market is anticipated to grow at a rapid rate owing to development in biotechnology and biomedical engineering. According to WHO, Cancer is the leading cause of mortality and morbidity globally impacting about 14 million people annually, leading to rapid increase in research activities worldwide. Circulating tumor cells and cancer stem cells are under research for various types of cancer such as breast cancer, lung cancer, colorectal cancer, skin cancer. Government and various government bodies are taking interest and initiative to boost funds and activities which is one of the major factor driving the growth of the global circulating tumor cells and cancer stem cells market.
Market Analysis and Insights: Global Circulating Tumor Cells and Cancer Stem Cells Market
The global Circulating Tumor Cells and Cancer Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Circulating Tumor Cells and Cancer Stem Cells Scope and Market Size
Circulating Tumor Cells and Cancer Stem Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells and Cancer Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
QIAGEN Hannover
AVIVA Biosciences
Epic Sciences
ApoCell
Cynvenio Biosystems
Fluxion Biosciences
Rarecells
Janssen Diagnostics
CellTraffix
Silicon Biosystems
Advanced Cell Diagnostics
Market segment by Type, the product can be split into
Cell Enrichment
Detection
CTC Analysis
Market segment by Application, split into
Hospital
NSC
Medical Research Institute
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cells and Cancer Stem Cells Revenue
1.4 Market by Type
1.4.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Enrichment
1.4.3 Detection
1.4.4 CTC Analysis
1.5 Market by Application
1.5.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 NSC
1.5.4 Medical Research Institute
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cells and Cancer Stem Cells Growth Trends by Regions
2.2.1 Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cells and Cancer Stem Cells Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Circulating Tumor Cells and Cancer Stem Cells Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Tumor Cells and Cancer Stem Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Market Size
3.1.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio
3.2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2019
3.3 Circulating Tumor Cells and Cancer Stem Cells Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cells and Cancer Stem Cells Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cells and Cancer Stem Cells Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
6.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
7.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
8 China
8.1 China Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
8.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in China (2019-2020)
8.3 China Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
9.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
10.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
11 India
11.1 India Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
11.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in India (2019-2020)
11.3 India Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size (2015-2020)
12.2 Circulating Tumor Cells and Cancer Stem Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 QIAGEN Hannover
13.1.1 QIAGEN Hannover Company Details
13.1.2 QIAGEN Hannover Business Overview
13.1.3 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Introduction
13.1.4 QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020))
13.1.5 QIAGEN Hannover Recent Development
13.2 AVIVA Biosciences
13.2.1 AVIVA Biosciences Company Details
13.2.2 AVIVA Biosciences Business Overview
13.2.3 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
13.2.4 AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.2.5 AVIVA Biosciences Recent Development
13.3 Epic Sciences
13.3.1 Epic Sciences Company Details
13.3.2 Epic Sciences Business Overview
13.3.3 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Introduction
13.3.4 Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.3.5 Epic Sciences Recent Development
13.4 ApoCell
13.4.1 ApoCell Company Details
13.4.2 ApoCell Business Overview
13.4.3 ApoCell Circulating Tumor Cells and Cancer Stem Cells Introduction
13.4.4 ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.4.5 ApoCell Recent Development
13.5 Cynvenio Biosystems
13.5.1 Cynvenio Biosystems Company Details
13.5.2 Cynvenio Biosystems Business Overview
13.5.3 Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
13.5.4 Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.5.5 Cynvenio Biosystems Recent Development
13.6 Fluxion Biosciences
13.6.1 Fluxion Biosciences Company Details
13.6.2 Fluxion Biosciences Business Overview
13.6.3 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
13.6.4 Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.6.5 Fluxion Biosciences Recent Development
13.7 Rarecells
13.7.1 Rarecells Company Details
13.7.2 Rarecells Business Overview
13.7.3 Rarecells Circulating Tumor Cells and Cancer Stem Cells Introduction
13.7.4 Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.7.5 Rarecells Recent Development
13.8 Janssen Diagnostics
13.8.1 Janssen Diagnostics Company Details
13.8.2 Janssen Diagnostics Business Overview
13.8.3 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
13.8.4 Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.8.5 Janssen Diagnostics Recent Development
13.9 CellTraffix
13.9.1 CellTraffix Company Details
13.9.2 CellTraffix Business Overview
13.9.3 CellTraffix Circulating Tumor Cells and Cancer Stem Cells Introduction
13.9.4 CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.9.5 CellTraffix Recent Development
13.10 Silicon Biosystems
13.10.1 Silicon Biosystems Company Details
13.10.2 Silicon Biosystems Business Overview
13.10.3 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
13.10.4 Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
13.10.5 Silicon Biosystems Recent Development
13.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Company Details
10.11.2 Advanced Cell Diagnostics Business Overview
10.11.3 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
10.11.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020)
10.11.5 Advanced Cell Diagnostics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Circulating Tumor Cells and Cancer Stem Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Tumor Cells and Cancer Stem Cells Revenue
Table 3. Ranking of Global Top Circulating Tumor Cells and Cancer Stem Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Enrichment
Table 6. Key Players of Detection
Table 7. Key Players of CTC Analysis
Table 8. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2015-2020)
Table 12. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Circulating Tumor Cells and Cancer Stem Cells Market Growth Strategy
Table 18. Main Points Interviewed from Key Circulating Tumor Cells and Cancer Stem Cells Players
Table 19. Global Circulating Tumor Cells and Cancer Stem Cells Revenue by Players (2015-2020) (Million US$)
Table 20. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players (2015-2020)
Table 21. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2019)
Table 22. Global Circulating Tumor Cells and Cancer Stem Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Circulating Tumor Cells and Cancer Stem Cells Product Solution and Service
Table 25. Date of Enter into Circulating Tumor Cells and Cancer Stem Cells Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 28. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Share by Type (2015-2020)
Table 29. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2021-2026)
Table 30. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Share by Application (2015-2020)
Table 31. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 32. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Share by Application (2021-2026)
Table 33. North America Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 35. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 36. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 37. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 38. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 39. Europe Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 41. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 43. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 45. China Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 46. China Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 47. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 48. China Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 49. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 50. China Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 51. Japan Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 53. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 55. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 59. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 61. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 63. India Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 64. India Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 65. India Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 66. India Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 67. India Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 68. India Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Circulating Tumor Cells and Cancer Stem Cells Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Circulating Tumor Cells and Cancer Stem Cells Market Share (2019-2020)
Table 71. Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2015-2020)
Table 73. Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2015-2020)
Table 75. QIAGEN Hannover Company Details
Table 76. QIAGEN Hannover Business Overview
Table 77. QIAGEN Hannover Product
Table 78. QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 79. QIAGEN Hannover Recent Development
Table 80. AVIVA Biosciences Company Details
Table 81. AVIVA Biosciences Business Overview
Table 82. AVIVA Biosciences Product
Table 83. AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 84. AVIVA Biosciences Recent Development
Table 85. Epic Sciences Company Details
Table 86. Epic Sciences Business Overview
Table 87. Epic Sciences Product
Table 88. Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 89. Epic Sciences Recent Development
Table 90. ApoCell Company Details
Table 91. ApoCell Business Overview
Table 92. ApoCell Product
Table 93. ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 94. ApoCell Recent Development
Table 95. Cynvenio Biosystems Company Details
Table 96. Cynvenio Biosystems Business Overview
Table 97. Cynvenio Biosystems Product
Table 98. Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 99. Cynvenio Biosystems Recent Development
Table 100. Fluxion Biosciences Company Details
Table 101. Fluxion Biosciences Business Overview
Table 102. Fluxion Biosciences Product
Table 103. Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 104. Fluxion Biosciences Recent Development
Table 105. Rarecells Company Details
Table 106. Rarecells Business Overview
Table 107. Rarecells Product
Table 108. Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 109. Rarecells Recent Development
Table 110. Janssen Diagnostics Business Overview
Table 111. Janssen Diagnostics Product
Table 112. Janssen Diagnostics Company Details
Table 113. Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 114. Janssen Diagnostics Recent Development
Table 115. CellTraffix Company Details
Table 116. CellTraffix Business Overview
Table 117. CellTraffix Product
Table 118. CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 119. CellTraffix Recent Development
Table 120. Silicon Biosystems Company Details
Table 121. Silicon Biosystems Business Overview
Table 122. Silicon Biosystems Product
Table 123. Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 124. Silicon Biosystems Recent Development
Table 125. Advanced Cell Diagnostics Company Details
Table 126. Advanced Cell Diagnostics Business Overview
Table 127. Advanced Cell Diagnostics Product
Table 128. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2015-2020) (Million US$)
Table 129. Advanced Cell Diagnostics Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Type: 2020 VS 2026
Figure 2. Cell Enrichment Features
Figure 3. Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. NSC Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Circulating Tumor Cells and Cancer Stem Cells Report Years Considered
Figure 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions: 2020 VS 2026
Figure 12. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players in 2019
Figure 15. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2019
Figure 17. North America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
- 臍帯血幹細胞の世界市場（～2026年） Market Analysis and Insights: Global Cord Blood Stem Cells Market The global Cord Blood Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cord Blood Stem Cells Scope and Market Size Cord Blood Stem Cells marke…
- 循環腫瘍細胞（CTC）の世界市場（～2026年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…